Skip navigation and go to main content

Perspectives / Press Releases

Latest Research & Updates

Insights, analysis, and thought leadership from the Forma team on pharmaceutical development and manufacturing.

Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

Aug 12, 2026 1:00 PM Eastern Daylight Time U.S. manufacturing agreement advances Cycle’s preparations to introduce CAVHANZA to patients with…

Press Releases

Learn More
Forma Life Sciences Launches U.S. Based Contract Development and Manufacturing Organization (CDMO) for Oral Solid Dosage Development and Commercial Manufacturing in Irvine, California

Mar 3, 2026 11:00 AM Eastern Standard Time IRVINE, Calif.–(BUSINESS WIRE)–Forma Life Sciences, Inc. today announced its launch as an…

Press Releases

Learn More
BioSelective Capital Investments Completes Acquisition of BioDuro’s Irvine, California Drug Product Development and Manufacturing Operations

Feb 4, 2026 10:00 AM Eastern Standard Time PARK CITY, Utah & IRVINE, Calif.–(BUSINESS WIRE)–BioSelective Capital Investments and Shayan Enterprises, LLC,…

Press Releases

Learn More